[Wrong information concerning rofecoxib].
Rygnestad
Tarjei
T
Seksjon for klinisk farmakologi Avdeling for legemidler St. Olavs Hospital 7006 Trondheim. tarjei.rygnestad@medisin.ntnu.no
Slørdal
Lars
L
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D004346:Drug Information Services; D006801:Humans; D007783:Lactones / Q000009:adverse effects / Q000627:therapeutic use*; D013450:Sulfones
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib